Pharmacy retailer, MedPlus, is planning to come up with an Initial Public Offer (IPO) soon.
“We will be commencing the process including works such as Draft Red Herring Prospectus,” Madhukar Gangadi, Founder and CEO, MedPlus told newspersons here on Wednesday.
The size of the proposed IPO of the Hyderabad-based pharmacy chain is likely to be over Rs 700 crore.
Gangadi (promoters) has 77 per cent stake in the company while Azim Premji and others have 13 pc and 10 pc stake respectively.
“In India, people expect company to be making profit when they go public. I feel we are now in right time for this,” he said.
MedPlus to expected to close the year with a net profit of Rs 50 crore and over Rs 2800 crore revenue, he said. It had earlier planned for a pubic issue but did not proceed with it.
Expansion
With 1700 retail outlets across the southern states, MedPlus will now be expanding to the northern market leaving aside Jammu & Kashmir, Bihar and parts of Uttar Pradesh, Gangadi said. By 2023, it expecting to have about 3100 outlets across the country.
“We are able to seamlessly integrate offline and online model. About 18 per cent of our sales now come from online. This model will be way forward for us,” he added.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.